Commentary: In search of answers regarding the benefits and harms of short term ADT for intermediate-risk prostate cancer
- PMID: 28263133
Commentary: In search of answers regarding the benefits and harms of short term ADT for intermediate-risk prostate cancer
Comment on
-
The need for androgen deprivation therapy in patients with intermediate-risk prostate cancer treated with dose-escalated external beam radiation therapy.Can J Urol. 2017 Feb;24(1):8656-8662. Can J Urol. 2017. PMID: 28263132
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical